Skip to content

Clinical trials

Terminated Lymphoma, Non-Hodgkin trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Status: Terminated Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20161
20171
20191
20201
20213
20223
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Adagene (Suzhou) Limited1
Antengene Corporation1
Antengene Therapeutics Limited1
Axter Therapeutics (Beijing) Co., Ltd1
Bayer1
BeOne Medicines1
BioNova Pharmaceuticals (Shanghai) LTD.1
Changchun GeneScience Pharmaceutical Co., Ltd.1
Chipscreen Biosciences, Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin14
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Follicular3
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Mantle-Cell2
Recurrence2
Carcinoma, Renal Cell1
Hereditary Sensory and Autonomic Neuropathies1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, B-Cell1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.